InfuSystem Holdings, Inc·4

May 14, 6:28 PM ET

Eichenbaum Kenneth D. 4

Research Summary

AI-generated summary

Updated

InfuSystem (INFU) Director Kenneth D. Eichenbaum Receives Option Award

What Happened
Kenneth D. Eichenbaum, a director of InfuSystem Holdings, Inc. (INFU), received a derivative award on 2026-05-12: an option representing the right to purchase 24,890 shares of common stock. The Form 4 reports the transaction as an award (code A) with a reported price of $0.00 and a reported value of $0 (derivative). This is a grant of an equity right, not an immediate open-market purchase or sale.

Key Details

  • Transaction date: 2026-05-12; Form filed: 2026-05-14 (filed within the usual 2-business-day window).
  • Reported transaction: Grant/award of an option for 24,890 shares; price shown as $0.00 and reported value $0 (derivative).
  • Vesting: The option "vests on May 12, 2027" (footnote).
  • Shares owned after the transaction: Not specified in the filing.
  • Transaction code: A = Award/Grant. No 10b5-1 plan, tax withholding, or immediate exercise/sale noted.

Context
This award gives the director the right to purchase shares in the future if and when the option vests and is exercised; it does not change current share ownership or result in proceeds until exercised and, if applicable, sold. Such option grants are common for directors as part of compensation and are informational rather than a direct buy/sell signal.